"Acute myeloid leukemia patients" trang 1 - tải miễn phí từ tailieunhanh
Frequency and prognostic significant of CYP3A4- A-290G polymorphism in acute myeloid leukemia

Frequency and prognostic significant of CYP3A4- A-290G polymorphism in acute myeloid leukemia
5    72    0
Volasertib as a monotherapy or in combination with azacitidine in patients with myelodysplastic syndrome, chronic myelomonocytic leukemia, or acute myeloid leukemia: Summary of three phase I studies

Volasertib as a monotherapy or in combination with azacitidine in patients with myelodysplastic syndrome, chronic myelomonocytic leukemia, or acute myeloid leukemia: Summary of three phase I studies
9    32    1
Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome

Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome
14    74    0
A study on effectiveness of leukepheresis in patients with hyperleukocytic leukemias

A study on effectiveness of leukepheresis in patients with hyperleukocytic leukemias
7    38    1
Quantitative detection of circulating nucleophosmin mutations DNA in the plasma of patients with acute myeloid leukemia

Quantitative detection of circulating nucleophosmin mutations DNA in the plasma of patients with acute myeloid leukemia
6    81    0
Are social inequalities in acute myeloid leukemia survival explained by differences in treatment utilization? Results from a French longitudinal observational study among older patients

Are social inequalities in acute myeloid leukemia survival explained by differences in treatment utilization? Results from a French longitudinal observational study among older patients
12    94    0
DECIDER: Prospective randomized multicenter phase II trial of low-dose decitabine (DAC) administered alone or in combination with the histone deacetylase inhibitor valproic acid (VPA) and all-trans retinoic acid (ATRA) in patients > 60 years with acute myeloid leukemia who are ineligible for induction chemotherapy

DECIDER: Prospective randomized multicenter phase II trial of low-dose decitabine (DAC) administered alone or in combination with the histone deacetylase inhibitor valproic acid (VPA) and all-trans retinoic acid (ATRA) in patients > 60 years with acute myeloid leukemia who are ineligible for induction chemotherapy
8    62    1
Establishment of a diagnostic procedure and preliminary scanning for length mutations in cebpa/bzip domain in Vietnamese acute myeloid leukemia patients

Establishment of a diagnostic procedure and preliminary scanning for length mutations in cebpa/bzip domain in Vietnamese acute myeloid leukemia patients
6    45    0
Long-term outcome of childhood acute myeloid leukemia at Hue Central Hospital

Long-term outcome of childhood acute myeloid leukemia at Hue Central Hospital
6    92    0
Circ-Foxo3 is positively associated with the Foxo3 gene and leads to better prognosis of acute myeloid leukemia patients

Circ-Foxo3 is positively associated with the Foxo3 gene and leads to better prognosis of acute myeloid leukemia patients
11    50    0
Low-dose decitabine priming with intermediate-dose cytarabine followed by umbilical cord blood infusion as consolidation therapy for elderly patients with acute myeloid leukemia: A phase II single-arm study

Low-dose decitabine priming with intermediate-dose cytarabine followed by umbilical cord blood infusion as consolidation therapy for elderly patients with acute myeloid leukemia: A phase II single-arm study
8    82    0
The prognostic impact of tet oncogene family member 2 mutations in patients with acute myeloid leukemia: A systematicreview and meta-analysis

The prognostic impact of tet oncogene family member 2 mutations in patients with acute myeloid leukemia: A systematicreview and meta-analysis
11    89    0
Prognostic value of platelet recovery degree before and after achieving minimal residual disease negative complete remission in acute myeloid leukemia patients

Prognostic value of platelet recovery degree before and after achieving minimal residual disease negative complete remission in acute myeloid leukemia patients
8    34    1
Monitoring of post-transplant MLL-PTD as minimal residual disease can predict relapse after allogeneic HSCT in patients with acute myeloid leukemia and myelodysplastic syndrome

Monitoring of post-transplant MLL-PTD as minimal residual disease can predict relapse after allogeneic HSCT in patients with acute myeloid leukemia and myelodysplastic syndrome
11    58    3
Prognostic value of IDH2R140 and IDH2R172 mutations in patients with acute myeloid leukemia: A systematic review and meta-analysis

Prognostic value of IDH2R140 and IDH2R172 mutations in patients with acute myeloid leukemia: A systematic review and meta-analysis
14    5    1
Association between serum albumin and 60-day mortality in Chinese Hakka patients with non-APL acute myeloid leukemia: A retrospective cohort study

Association between serum albumin and 60-day mortality in Chinese Hakka patients with non-APL acute myeloid leukemia: A retrospective cohort study
9    1    1
Influence on therapeutic outcome of platelet count at diagnosis in patients with de novo non-APL acute myeloid leukemia

Influence on therapeutic outcome of platelet count at diagnosis in patients with de novo non-APL acute myeloid leukemia
9    6    1
Outcome and prognostic factors of CBF pediatric AML patients with t(8;21) differ from patients with inv(16)

Outcome and prognostic factors of CBF pediatric AML patients with t(8;21) differ from patients with inv(16)
13    7    1
Báo cáo y học:

Báo cáo y học: "Hypocellular acute myeloid leukemia with bone marrow necrosis in young patients: two case report"
4    31    0
báo cáo hóa học:

báo cáo hóa học:" High correlation of the proteome patterns in bone marrow and peripheral blood blast cells in patients with acute myeloid leukemia"
8    42    0